Summary
40 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 13% a year over the last 3 years.
- Operating profit covers the interest on its debt only 2.6 times.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
Revenue fell by 8.6% a year over 5 years. Over the last 3 years it fell by 13% a year.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $1.57M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 6.2 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 2
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $3 is 1,264% above today's price. 33% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2022By product
- Tuition 88%
- Course Fees 10%
- Exam Fees 1.0%
- Service Fees 0.9%
- Book Fees 0.1%
By region
The company reports no revenue by region.
Tuition brings in 88% of revenue. Exam Fees grew fastest, by 62% a year.
Segments in detail